Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes

NCT01175473 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Lixisenatide (AVE0010)
DEVICE: Pen auto-injector
DRUG: Liraglutide
DEVICE: Pre-filled pen injector
DRUG: Metformin

Sponsor

Sanofi